These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 18337219)

  • 1. Cyclodextrins.
    Stella VJ; He Q
    Toxicol Pathol; 2008 Jan; 36(1):30-42. PubMed ID: 18337219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cholesterol depletion as a marker of nephrotoxicity in vitro for novel β-cyclodextrin derivatives.
    Wang H; Xie X; Zhang F; Zhou Q; Tao Q; Zou Y; Chen C; Zhou C; Yu S
    Food Chem Toxicol; 2011 Jun; 49(6):1387-93. PubMed ID: 21426923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
    Stojanov M; Nielsen HM; Larsen KL
    Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
    Holvoet C; Heyden YV; Plaizier-Vercammen J
    Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals.
    Thompson DO
    Crit Rev Ther Drug Carrier Syst; 1997; 14(1):1-104. PubMed ID: 9043816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrins.
    Kurkov SV; Loftsson T
    Int J Pharm; 2013 Aug; 453(1):167-80. PubMed ID: 22771733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of preparation method on itraconazole oral solutions using cyclodextrins as complexing agents.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Pharmazie; 2007 Jul; 62(7):510-4. PubMed ID: 17718191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems.
    Brewster ME; Loftsson T
    Pharmazie; 2002 Feb; 57(2):94-101. PubMed ID: 11878196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrin derivatives in pharmaceutics.
    Albers E; Müller BW
    Crit Rev Ther Drug Carrier Syst; 1995; 12(4):311-37. PubMed ID: 9501966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.
    Jarho P; Vander Velde D; Stella VJ
    J Pharm Sci; 2000 Feb; 89(2):241-9. PubMed ID: 10688753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the influence of cyclodextrins on oral absorption of low-solubility drugs: I. Model development.
    Gamsiz ED; Miller L; Thombre AG; Ahmed I; Carrier RL
    Biotechnol Bioeng; 2010 Feb; 105(2):409-20. PubMed ID: 19725042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dissolution of nimodipine in an aqueous solution of hydroxyethyl-beta-cyclodextrin and a review of solubility of nimodipine with cyclodextrins].
    Kopecký F; Kopecká B; Kaclík P
    Ceska Slov Farm; 2003 Jan; 52(1):33-8. PubMed ID: 12685332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery.
    Rajewski RA; Stella VJ
    J Pharm Sci; 1996 Nov; 85(11):1142-69. PubMed ID: 8923319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled cyclodextrin aggregates and nanoparticles.
    Messner M; Kurkov SV; Jansook P; Loftsson T
    Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion.
    Fukuda M; Miller DA; Peppas NA; McGinity JW
    Int J Pharm; 2008 Feb; 350(1-2):188-96. PubMed ID: 17920217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a sulfobutyl ether beta-cyclodextrin as a solubilizing/stabilizing agent for several drugs.
    Ueda H; Ou D; Endo T; Nagase H; Tomono K; Nagai T
    Drug Dev Ind Pharm; 1998 Sep; 24(9):863-7. PubMed ID: 9876538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of beta-cyclodextrin and its water-soluble derivatives on in vitro drug transport across rat intestinal epithelium.
    Zheng Y; Zuo Z; Chow AH
    Int J Pharm; 2006 Feb; 309(1-2):123-8. PubMed ID: 16359834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.